References
- Adzhubei I, Jordan DM, Sunyaev SR. 2013. Predicting functional effect of human missense mutations using PolyPhen 2. Curr Protoc Hum Genet. 76:21–27.
- Afonina I, Zivarts M, Kutyavin I, Lukhtanov E, Gamper H, Meyer RB. 1997. Efficient priming of PCR with short oligonucleotides conjugated to a minor groove binder. Nucleic Acids Res. 25:2657–60.
- Alam J, Jantan I, Bukhari SNA. 2017. Rheumatoid arthritis: recent advances on its etiology, role of cytokines and pharmacotherapy. Biomed Pharmacother. 92:615–33.
- Amr K, El-Awady R, Raslan H. 2016. Assessment of the −174G/C (rs1800795) and −572G/C (rs1800796) interleukin 6 gene polymorphisms in Egyptian patients with rheumatoid arthritis. Maced J Med Sci. 4:574.
- Bogunia-Kubik K, Świerkot J, Malak A, Wysoczańska B, Nowak B, Białowąs K, Gębura K, Korman L, Wiland P. 2015. IL-17A, IL-17F and IL-23R gene polymorphisms in Polish patients with rheumatoid arthritis. Arch Immunol Ther Exp. 63:215–21.
- Bossert M, Prati C, Vidal C, Bongain S, Toussirot E, Wendling D. 2012. Evaluation of self-report questionnaires for assessing rheumatoid arthritis activity: A cross-sectional study of RAPID3 and RADAI5 and flare detection in 200 patients. Joint Bone Spine. 79:57–62.
- Calabresi E, Petrelli F, Bonifacio A, Puxeddu I, Alunno A. 2018. One year in review. pathogenesis of rheumatoid arthritis. Clin Exp Rheumatol. 36:175–84.
- Case DA, Cheatham TE, Darden T, Gohlke H, Luo R, Merz KM, Onufriev A, Simmerling C, Wang B, Woods RJ. 2005. The Amber biomolecular simulation programs. J Comp Chem. 26:1668–88.
- David A, Razali R, Wass MN, Sternberg MJ. 2012. Protein–protein interaction sites are hot spots for disease associated nonsynonymous SNPs. Human Mutat. 33:359–63.
- Ely LK, Fischer S, Garcia KC. 2009. Structural basis of receptor sharing by interleukin 17 cytokines. Nat Immunol. 10:1245.
- Emonts M, Hazes MJ, Houwing-Duistermaat JJ, van der Gaast-de CE, de Vogel L, Han HK, Wouters JM, Laman JD, Dolhain RJ. 2011. Polymorphisms in genes controlling inflammation and tissue repair in rheumatoid arthritis: a case control study. BMC Med Genet. 12:36.
- Fakhr A, Hakim F, Zaidi SK, Yusuf R, Sharif A. 2017. Clinical registry for Pakistan: A preliminary analysis. Pak Armed Forces Med J. 67(2):317–21.
- Fariselli P, Martelli PL, Savojardo CR. 2015. INPS: predicting the impact of non-synonymous variations on protein stability from sequence. Bioinformatics. 31:2816–21.
- Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S, Woo P. 1998. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest. 102:1369–76.
- Frappier V, Chartier M, Najmanovich RJ. 2015. ENCoM server: exploring protein conformational space and the effect of mutations on protein function and stability. Nucleic Acids Res. 43:W395–W400.
- Frisell T, Hellgren K, Alfredsson L, Raychaudhuri S, Klareskog L, Askling J. 2016. Familial aggregation of arthritis-related diseases in seropositive and seronegative rheumatoid arthritis: a register-based case-control study in Sweden. Ann Rheum Dis. 75:183–89.
- Gaffen SL. 2009. Structure and signalling in the IL-17 receptor family. Nat Rev Immunol. 9:556.
- Gautam S, Kumar U, Kumar M, Kanga U, Dada R. 2019. Association of HLA-G 3ʹUTR polymorphisms with soluble HLA-G levels and disease activity in patients with rheumatoid arthritis: A case-control study. Immunol Invest. 49:88–105.
- Goepfert A, Lehmann S, Wirth E, Rondeau JM. 2017. The human IL-17A/F heterodimer: a two-faced cytokine with unique receptor recognition properties. Sci Rep. 7:8906.
- Hot A, Miossec P. 2011. Effects of interleukin (IL)-17A and IL-17F in human rheumatoid arthritis synoviocytes. Ann Rheum Dis. 70:727–32.
- Hou T, Wang J, Li Y, Wang W. 2010. Assessing the performance of the MM/PBSA and MM/GBSA methods. 1. The accuracy of binding free energy calculations based on molecular dynamics simulations. J Chem Inf Model. 51:69–82.
- Huang LT, Gromiha MM, Ho SY. 2007a. iPTREE-STAB: interpretable decision tree-based method for predicting protein stability changes upon mutations. Bioinformatics. 23:1292–93.
- Huang X, Zhuang J, Ren Y, Zhou L, Zhou Q. 2007b. Association of interleukin-6 and interleukin-18 gene polymorphism with rheumatoid arthritis in Guangdong Han population. J Southern Med Univer. 27:1661–64.
- Huizinga TW, Machold KP, Breedveld FC, Lipsky PE, Smolen JS. 2002. Criteria for early rheumatoid arthritis: from Bayes’ law revisited to new thoughts on pathogenesis. Arthritis Rheumatism. 46:1155–59.
- Lubberts E. 2008. IL-17/Th17 targeting: on the road to prevent chronic destructive arthritis? Cytokine. 41:84–91.
- MacGregor AJ, Snieder H, Rigby AS, Koskenvuo M, Kaprio J, Aho K, Silman AJ. 2000. Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheumatism. 43:30–37.
- Mader SS, Windelspecht M. 2018. Biology. 13th ed. New York (NY): McGraw-Hill.
- Massova I, Kollman PA. 2000. Combined molecular mechanical and continuum solvent approach (MM-PBSA/GBSA) to predict ligand binding. Perspectives Drug Discov Design. 18:113–35.
- Ng PC, Henikoff S. 2003. SIFT: predicting amino acid changes that affect protein function. Nucleic Acids Res. 31:3812–14.
- Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, Ferrin TE. 2004. UCSF Chimera—a visualization system for exploratory research and analysis. J Comput Chem. 25:1605–12.
- Roberson ED, Bowcock AM. 2010. Psoriasis genetics: breaking the barrier. Trends Genet. 26:415–23.
- Roe DR, Cheatham TE. 2013. III. PTRAJ and CPPTRAJ: software for processing and analysis of molecular dynamics trajectory data. J Chem Theory Comput. 9:3084–95.
- Rossini M, Rossi E, Bernardi D, Viapiana O, Gatti D, Idolazzi L, Caimmi C, DeRosa M, Adami S. 2014. Prevalence and incidence of rheumatoid arthritis in Italy. Rheumatol Int. 34:659–64.
- Saeed S, Bonnefond A, Tamanini F, Mirza MU, Manzoor J, Janjua QM, Din SM, Gaitan J, Milochau A, Durand E. 2018. Loss-of-function mutations in ADCY3 cause monogenic severe obesity. Nat Genet. 50:175.
- Shen F, Gaffen SL. 2008. Structure–function relationships in the IL-17 receptor: implications for signal transduction and therapy. Cytokine. 41:92–104.
- Srirangan S, Choy EH. 2010. The role of interleukin 6 in the pathophysiology of rheumatoid arthritis. Therap Advan Musculo Dis. 2:247–56.
- Teng S, Madej T, Panchenko A, Alexov E. 2009. Modeling effects of human single nucleotide polymorphisms on protein-protein interactions. Biophys J. 96:2178–88.
- Teng S, Michonova-Alexova E, Alexov E. 2008. Approaches and resources for prediction of the effects of non-synonymous single nucleotide polymorphism on protein function and interactions. Current Pharma Biotechnol. 9:123–33.
- Teng S, Srivastava AK, Wang L. 2010. Sequence feature-based prediction of protein stability changes upon amino acid substitutions. BMC Genomics. 11:1.
- Toy D, Kugler D, Wolfson M, Bos TV, Gurgel J, Derry J, Tocker J, Peschon J. 2006. Cutting edge: interleukin 17 signals through a heteromeric receptor complex. J Immunol. 177:36–39.
- Wright JF, Bennett F, Li B, Brooks J, Luxenberg DP, Whitters MJ, Tomkinson KN, Fitz LJ, Wolfman NM, Collins M. 2008. The human IL-17F/IL-17A heterodimeric cytokine signals through the IL-17RA/IL-17RC receptor complex. J Immunol. 181:2799–805.